68180-0801 Lapatinib - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

68180-0801

Brand Name:

Lapatinib

Generic Name:

lapatinib

Dosage Form Name:

TABLET

Administration Route:

Oral

Substances:

Name: LAPATINIB DITOSYLATE

Strength: 250.0

Unit: mg/1

Packages:

Code: 68180-0801-36

Description: 150 TABLET in 1 BOTTLE (68180-801-36)

Effective Date: Sept. 29, 2020

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

EGFR/HER2

Orphan Drug Designation:

Status:

In Use